feed,title,long_url,short_url
SeekingAlpha,Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook,https://seekingalpha.com/news/4061930,
SeekingAlpha,"Exxon Mobil Non-GAAP EPS of $2.48 beats by $0.27, revenue of $84.34B misses by $4.48B",https://seekingalpha.com/news/4061929,
